These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 10725267

  • 1. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
    Calo' G, Guerrini R, Bigoni R, Rizzi A, Marzola G, Okawa H, Bianchi C, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2000 Mar; 129(6):1183-93. PubMed ID: 10725267
    [Abstract] [Full Text] [Related]

  • 2. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 4. [Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.
    Rizzi A, Bigoni R, Caló G, Guerrini R, Salvadori S, Regoli D.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):R3-5. PubMed ID: 10607891
    [Abstract] [Full Text] [Related]

  • 5. [Nphe(1)]nociceptin-(1-13)NH(2) selectively antagonizes nociceptin effects in the rabbit isolated ileum.
    Pheng LH, Calo G, Guerrini R, Regoli D.
    Eur J Pharmacol; 2000 Jun 02; 397(2-3):383-8. PubMed ID: 10844138
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G.
    J Pharmacol Exp Ther; 2007 Jun 02; 321(3):961-7. PubMed ID: 17329552
    [Abstract] [Full Text] [Related]

  • 7. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR, Glen T, Davies MR, Paterson SJ, Corbett AD.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):217-23. PubMed ID: 10607879
    [Abstract] [Full Text] [Related]

  • 8. Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice.
    Di Giannuario A, Rizzi A, Pieretti S, Guerrini R, Bertorelli R, Salvadori S, Regoli D, Calo G.
    Neurosci Lett; 2001 Dec 04; 316(1):25-8. PubMed ID: 11720770
    [Abstract] [Full Text] [Related]

  • 9. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H, Calo' G, Albrecht E, Guerrini R, Bienert M.
    J Pharmacol Exp Ther; 2000 Aug 04; 294(2):428-33. PubMed ID: 10900215
    [Abstract] [Full Text] [Related]

  • 10. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
    Bigoni R, Calo' G, Rizzi A, Guerrini R, De Risi C, Hashimoto Y, Hashiba E, Lambert DG, Regoli D.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 04; 361(5):565-8. PubMed ID: 10832612
    [Abstract] [Full Text] [Related]

  • 11. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S.
    J Med Chem; 2005 Mar 10; 48(5):1421-7. PubMed ID: 15743186
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H, Nicol B, Bigoni R, Hirst RA, Calo G, Guerrini R, Rowbotham DJ, Smart D, McKnight AT, Lambert DG.
    Br J Pharmacol; 1999 May 10; 127(1):123-30. PubMed ID: 10369464
    [Abstract] [Full Text] [Related]

  • 13. The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats.
    Corradini L, Briscini L, Ongini E, Bertorelli R.
    Brain Res; 2001 Jun 29; 905(1-2):127-33. PubMed ID: 11423087
    [Abstract] [Full Text] [Related]

  • 14. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
    Bigoni R, Rizzi A, Rizzi D, Becker JA, Kieffer BL, Simonin F, Regoli D, Calo G.
    Life Sci; 2000 Dec 01; 68(2):233-9. PubMed ID: 11191640
    [Abstract] [Full Text] [Related]

  • 15. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar 01; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 16. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
    Rizzi D, Rizzi A, Bigoni R, Camarda V, Marzola G, Guerrini R, De Risi C, Regoli D, Calo' G.
    J Pharmacol Exp Ther; 2002 Jan 01; 300(1):57-63. PubMed ID: 11752097
    [Abstract] [Full Text] [Related]

  • 17. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC, Fan SH, Guerrini R, Caló G.
    Neuropharmacology; 2002 Feb 01; 42(2):246-52. PubMed ID: 11804621
    [Abstract] [Full Text] [Related]

  • 18. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D.
    J Med Chem; 2000 Jul 27; 43(15):2805-13. PubMed ID: 10956188
    [Abstract] [Full Text] [Related]

  • 19. Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe(1))nociceptin(1-13)NH(2).
    Bytner B, Huang YH, Yu LC, Lundeberg T, Nylander I, Rosen A.
    Brain Res; 2001 Dec 13; 922(1):118-24. PubMed ID: 11730709
    [Abstract] [Full Text] [Related]

  • 20. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL, Chang M, Dong SL, Li W, Han RW, Fu GX, Chen Q, Wang R.
    Regul Pept; 2006 May 15; 134(2-3):75-81. PubMed ID: 16516988
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.